Medicine and Dentistry
Woman
76%
Human Immunodeficiency Virus
71%
Lesion
47%
Wart Virus
42%
Infection
34%
Human Papillomavirus Type 16
30%
Prevalence
27%
Cervical Cancer
23%
Genotype
21%
Human Papillomavirus Type 18
21%
Papanicolaou Stain
20%
Human Papillomavirus Type 58
18%
Human Papillomavirus Type 52
15%
Cells
14%
Follow up
14%
Incidence
13%
Screening
13%
Papillomavirus Infection
12%
Smear
11%
Cervical Cancer Screening
10%
Highly Active Antiretroviral Therapy
10%
Uterine Cervix Cytology
9%
Pathology
8%
Development
8%
Multiplex Polymerase Chain Reaction
8%
Evolution
8%
Detection Technique
8%
Study Design
8%
Polymerase Chain Reaction
8%
Patient
8%
Human Papillomavirus Type 33
7%
Capture
6%
Hybrid
6%
Antiretroviral Therapy
6%
Assay
5%
Malignant Neoplasm
5%
Cervical Screening
5%
Retrospective Cohort Study
5%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Wart Virus
57%
Genotype
32%
Human Papillomavirus Type 16
30%
Cells
27%
Sialoadhesin
25%
Prevalence
24%
CD4
23%
Uterine Cervix Mucosa
21%
Human Papillomavirus Type 18
21%
Human Papillomavirus Type 58
18%
Human Papillomavirus Type 52
15%
Human Immunodeficiency Virus Infection
12%
Tissues
12%
Screening
11%
Cancer Screening
10%
Sample
9%
Evolution
8%
Multiplex Polymerase Chain Reaction
8%
Interferon Type I
8%
Memory T Cell
8%
Human Papillomavirus Type 33
7%
Viral Load
6%
Hybrid
6%
Development
5%
Nursing and Health Professions
Woman
29%
Patient
29%
Infection
19%
Procedures
19%
Papillomavirus Infection
12%
Smear
11%
Uterine Cervix Cancer
11%
Highly Active Antiretroviral Therapy
10%
Screening
9%
DNA
8%
Prevalence
7%
Virus Load
6%
Hybrid
6%
Young Woman
5%
Sample
5%
Confidence Interval
5%
Malignant Neoplasm
5%
Assay
5%